TY - JOUR
T1 - Synthesis and preliminary in-vitro cytotoxic activity of novel substituted diaryl-imidazo [2,1,b]-benzothiazole derivatives
AU - Malik, Jitender K.
AU - Noolvi, Malleshappa N.
AU - Manvi, Fakkirappa V.
AU - Nanjwade, B. K.
AU - Patel, Harun M.
AU - Manjula, S. N.
AU - Mallikarjuna Rao, C.
AU - Barve, Ashutosh
N1 - cited By 2
PY - 2011/10
Y1 - 2011/10
N2 - A novel series of substituted diaryl imidazo[2,1-b]benzothiazole derivatives (8a-y) were synthesized by condensation reaction between 2-amino benzothiazole derivatives (3a-g) and substituted α-bromo-1, 2-(substituted) diaryl-1-ethanones (7a-i). The structures of the synthesized compounds were established by IR, 1H NMR, 13C NMR and mass spectroscopical data. The compounds (8a-y) were evaluated for their in-vitro cytotoxic activity on murine (B16F10) and human (MCF-7) cancer cells by using MTT assay. From the in vitro studies compounds 8p, 8u and 8y were found most effective with an IC50 range of 0.56-27.50 μM in MCF-7 and 2.57-36.54 μM in B16F10 cells.
AB - A novel series of substituted diaryl imidazo[2,1-b]benzothiazole derivatives (8a-y) were synthesized by condensation reaction between 2-amino benzothiazole derivatives (3a-g) and substituted α-bromo-1, 2-(substituted) diaryl-1-ethanones (7a-i). The structures of the synthesized compounds were established by IR, 1H NMR, 13C NMR and mass spectroscopical data. The compounds (8a-y) were evaluated for their in-vitro cytotoxic activity on murine (B16F10) and human (MCF-7) cancer cells by using MTT assay. From the in vitro studies compounds 8p, 8u and 8y were found most effective with an IC50 range of 0.56-27.50 μM in MCF-7 and 2.57-36.54 μM in B16F10 cells.
UR - http://www.scopus.com/inward/record.url?scp=80051956714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80051956714&partnerID=8YFLogxK
U2 - 10.2174/157018011796576015
DO - 10.2174/157018011796576015
M3 - Article
AN - SCOPUS:80051956714
SN - 1570-1808
VL - 8
SP - 717
EP - 724
JO - Letters in Drug Design and Discovery
JF - Letters in Drug Design and Discovery
IS - 8
ER -